BioSpace News Archive

Carve-out of Lonza Specialty Ingredients will help segment to become a global leader in microbial control

Lonza Group announced its intention to proceed with a carve-out of its Specialty Ingredients segment.

June 3, 2019
·
3 min read
AYOXXA launches the new LUNARISTM Reader designed to facilitate translational research in academic and industrial laboratories

AYOXXA Biosystems GmbH announces the launch of their next generation LUNARISTM Reader.

June 3, 2019
·
6 min read
Business

Florence Joins the Avoca Quality Consortium to Drive Technology Standardization Between Clinical Trial Sponsors and Sit

Florence announced its membership in the Avoca Quality Consortium® (AQC) to drive technology adoption and standardization in order to reduce drug costs and development time.

June 3, 2019
·
3 min read
Policy

FDA Compliant Blood Storage and Preservation

Accsense Monitoring System Automates Data Archive and Alarming

June 3, 2019
·
3 min read
Business

Lower-amp ECT appears effective against suicidal thoughts

Nearly half the amplitude typically used in standard electroconvulsive therapy (ECT) seems to be effective at treating suicidal thoughts, investigators report.

June 3, 2019
·
5 min read
Pharm Country

Proteomics International and PromarkerD at BIO 2019 saying 30 million diabetics in US deserve to know their future kidney disease status

PromarkerD world’s leading diagnostic test for diabetic kidney disease says Frost & Sullivan industry report ‘Biomarkers Enabling Diabetes and Obesity Management’

June 3, 2019
·
3 min read
Drug Development

Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers

Nivolumab plus ipilimumab meet primary endpoint of MD Anderson NEOSTAR Phase II trial

June 3, 2019
·
6 min read
Business

Great Bay Bio was Founded to Build a Platform for CMC Technology and Pre-Clinical Research and Development of Big Data Services for Innovative Drugs, Dr. Michael Chan as CEO

Great Bay Bio announced its formal establishment in Hong Kong and the Chairman, Mr. Kingsley Leung is pleased to appoint Mr. Michael Chan as CEO and co-founder of the company on behalf of the board.

June 3, 2019
·
8 min read
Business

WideTrial Partners With Oncotelic to Bring Expanded Access Platform to Cancer

WideTrial Inc., a third-party sponsor of Expanded Access programs, has begun a partnership with Oncotelic Inc., a wholly owned subsidiary of Mateon Therapeutics Inc., to provide OT-101 to patients who cannot take part in research trials of the investigational product.

June 3, 2019
·
1 min read
Drug Development

Arcutis Announces Initiation of Phase 2a Clinical Trial of ARQ-151 as a Potential Topical Treatment for Atopic Dermatitis

Arcutis, Inc. announced that it has enrolled the first patient in a Phase 2a clinical trial evaluating ARQ-151 as a potential treatment for atopic dermatitis (AD).

June 3, 2019
·
3 min read